138 related articles for article (PubMed ID: 25620080)
21. HLA-G 3' untranslated region polymorphisms influence the susceptibility for human papillomavirus infection.
Xu HH; Shi WW; Lin A; Yan WH
Tissue Antigens; 2014 Aug; 84(2):216-22. PubMed ID: 24758208
[TBL] [Abstract][Full Text] [Related]
22. BCRP gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma.
Hu LL; Wang XX; Chen X; Chang J; Li C; Zhang Y; Yang J; Jiang W; Zhuang SM
Carcinogenesis; 2007 Aug; 28(8):1740-4. PubMed ID: 17494054
[TBL] [Abstract][Full Text] [Related]
23. Human leukocyte antigen (HLA)-G during pregnancy part II: associations between maternal and fetal HLA-G genotypes and soluble HLA-G.
Dahl M; Klitkou L; Christiansen OB; Djurisic S; Piosik ZM; Skovbo P; Møller AM; Steffensen R; Hviid TV
Hum Immunol; 2015 Apr; 76(4):260-71. PubMed ID: 25637667
[TBL] [Abstract][Full Text] [Related]
24. Association of HLA-G +3142 C>G polymorphism and breast cancer in Tunisian population.
Zidi I; Dziri O; Zidi N; Sebai R; Boujelebene N; Ben Hassine A; Ben Yahia H; Laaribi AB; Babay W; Rifi H; Mezlini A; Chelbi H
Immunol Res; 2016 Aug; 64(4):961-8. PubMed ID: 26754763
[TBL] [Abstract][Full Text] [Related]
25. The association between functional HLA-G 14bp insertion/deletion and +3142 C>G polymorphisms and susceptibility to multiple sclerosis.
Ben Fredj N; Sakly K; Bortolotti D; Aissi M; Frih-Ayed M; Rotola A; Caselli E; Cura F; Sakly N; Aouni M; Di Luca D; Rizzo R
Immunol Lett; 2016 Dec; 180():24-30. PubMed ID: 27771469
[TBL] [Abstract][Full Text] [Related]
26. Association of MNS16A VNTR and hTERT rs2736098: G>A polymorphisms with susceptibility to diffuse large B-cell lymphoma.
Essa ES; Alagizy HA
Tumori; 2018 Jun; 104(3):165-171. PubMed ID: 28967095
[TBL] [Abstract][Full Text] [Related]
27. Influence of correlation between HLA-G polymorphism and Interleukin-6 (IL6) gene expression on the risk of schizophrenia.
Shivakumar V; Debnath M; Venugopal D; Rajasekaran A; Kalmady SV; Subbanna M; Narayanaswamy JC; Amaresha AC; Venkatasubramanian G
Cytokine; 2018 Jul; 107():59-64. PubMed ID: 29217401
[TBL] [Abstract][Full Text] [Related]
28. The Impact of
Ouni N; Chaaben AB; Kablouti G; Ayari F; Douik H; Abaza H; Gara S; Elgaaied-Benammar A; Guemira F; Tamouza R
Immunol Invest; 2019 Jul; 48(5):521-532. PubMed ID: 30945586
[TBL] [Abstract][Full Text] [Related]
29. Maternal homozygocity for a 14 base pair insertion in exon 8 of the HLA-G gene and carriage of HLA class II alleles restricting HY immunity predispose to unexplained secondary recurrent miscarriage and low birth weight in children born to these patients.
Christiansen OB; Kolte AM; Dahl M; Larsen EC; Steffensen R; Nielsen HS; Hviid TV
Hum Immunol; 2012 Jul; 73(7):699-705. PubMed ID: 22537754
[TBL] [Abstract][Full Text] [Related]
30. Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease.
Misra MK; Prakash S; Kapoor R; Pandey SK; Sharma RK; Agrawal S
Tissue Antigens; 2013 Nov; 82(5):317-26. PubMed ID: 24131018
[TBL] [Abstract][Full Text] [Related]
31. Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index.
Lech-Maranda E; Bienvenu J; Broussais-Guillaumot F; Warzocha K; Michallet AS; Robak T; Coiffier B; Salles G
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):131-41. PubMed ID: 20191326
[TBL] [Abstract][Full Text] [Related]
32. Polymorphism in IKZF1 gene affects clinical outcome in diffuse large B-cell lymphoma.
Bielska M; Borowiec M; Jesionek-Kupnicka D; Braun M; Bojo M; Pastorczak A; Kalinka-Warzocha E; Prochorec-Sobieszek M; Robak T; Warzocha K; Młynarski W; Lech-Marańda E
Int J Hematol; 2017 Dec; 106(6):794-800. PubMed ID: 28879630
[TBL] [Abstract][Full Text] [Related]
33. Impact of HLA-G 14-bp polymorphism on acute rejection and cytomegalovirus infection in kidney transplant recipients from northwestern China.
Jin ZK; Xu CX; Tian PX; Xue WJ; Ding XM; Zheng J; Ding CG; Ge GQ; Mao TC; Lin Y
Transpl Immunol; 2012 Oct; 27(2-3):69-74. PubMed ID: 22750489
[TBL] [Abstract][Full Text] [Related]
34. The HLA-G Genetic Contribution to Bipolar Disorder: A Trans-Ethnic Replication.
Sundaresh A; Wu CL; Chinnadurai RK; Rajkumar RP; Mariaselvam CM; LeMaoult J; Krishnamoorthy R; Leboyer M; Negi VS; Tamouza R
Immunol Invest; 2018 Aug; 47(6):593-604. PubMed ID: 29737889
[TBL] [Abstract][Full Text] [Related]
35. The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis.
Chiusolo P; Bellesi S; Piccirillo N; Giammarco S; Marietti S; De Ritis D; Metafuni E; Stignani M; Baricordi OR; Sica S; Leone G; Rizzo R
Bone Marrow Transplant; 2012 Jan; 47(1):120-4. PubMed ID: 21399669
[TBL] [Abstract][Full Text] [Related]
36. 3'UTR-HLA-G polymorphisms and circulating sHLA-G are associated with breast cancer: Evidence from a meta-analysis.
Tizaoui K; Jalouli M; Ouzari HI; Harrath AH; Rizzo R; Boujelbene N; Zidi I
Immunol Lett; 2022 Aug; 248():78-89. PubMed ID: 35752280
[TBL] [Abstract][Full Text] [Related]
37. HLA-G gene 14-bp deletion variant protects Iranian subjects against chronic hepatitis B infection.
Eskandari E; Dahmardeh T; Safdari V; Khosravi S; Pahlevani E
Int J Immunogenet; 2017 Dec; 44(6):322-327. PubMed ID: 28929613
[TBL] [Abstract][Full Text] [Related]
38. Associations between fetal HLA-G genotype and birth weight and placental weight in a large cohort of pregnant women - Possible implications for HLA diversity.
Emmery J; Christiansen OB; Nilsson LL; Dahl M; Skovbo P; Møller AM; Steffensen R; Hviid TVF
J Reprod Immunol; 2017 Apr; 120():8-14. PubMed ID: 28267635
[TBL] [Abstract][Full Text] [Related]
39. CD38 and interleukin 6 gene polymorphism in egyptians with diffuse large B-cell lymphoma (DLBCL).
Talaat RM; Abdel-Aziz AM; El-Maadawy EA; Abdel-Bary N
Immunol Invest; 2015; 44(3):265-78. PubMed ID: 25564959
[TBL] [Abstract][Full Text] [Related]
40. HLA-G 3'UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients.
Vaquero-Yuste C; Juarez I; Molina-Alejandre M; Molanes-López EM; López-Nares A; Suárez-Trujillo F; Gutiérrez-Calvo A; López-García A; Lasa I; Gómez R; Fernández-Cruz E; Rodrígez-Sainz C; Arnaiz-Villena A; Martín-Villa JM
Front Immunol; 2021; 12():698438. PubMed ID: 34557189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]